High Response Rates and Prolonged Survival in Patients With Corticotroph Pituitary Tumors and Refractory Cushing Disease From Capecitabine and Temozolomide (CAPTEM): A Case Series

Zacharia, Brad E.; Gulati, Anthony P.; Bruce, Jeffrey N.; More

Neurosurgery . 74(4):E447-E455, April 2014.